Cochlear Implants and the Aided Audiogram: A Retrospective Study Comparing Performance Across Device Manufacturers

Background/Objectives: We investigated: (1) differences in CI-aided thresholds and speech perception scores among cochlear implant manufacturers and (2) the relationship between CI-aided thresholds and speech perception. Methods: We analyzed exploratory data from NYU and a confirmatory data set of 120 CI-aided audiograms from the ASAN clinic. CI-aided soundfield evaluations were compared between manufacturers (Cochlear, Advanced Bionics, MED-EL) using 5- and 6-pure-tone average thresholds; percentage of patients with average thresholds above 35 dB HL; speech perception scores; and correlations between thresholds and speech perception. Results: Compared to Cochlear users, MED-EL and Advanced Bionics users had significantly higher (poorer) pure-tone averages (26.7 dB HL for Cochlear vs. 30.0 dB HL for AB and 34.6 dB HL for MED-EL at NYU; 29.0 dB HL for Cochlear vs. 36.5 dB HL for MED-EL at ASAN), and higher incidence of 5- or 6-PTAs above 35 dB HL (1.6% vs. 23.4%/47.1% at NYU; 11.2% vs. 60.0% at ASAN). Word and sentence scores were significantly higher for the Cochlear group when compared to the MED-EL group. Speech scores were higher for manufacturers that recommend the use of behaviorally-measured T-levels (Cochlear) rather than estimated T-levels (AB and MED-EL). Significant negative correlations existed between CI-aided thresholds and speech scores. Conclusions: Significant differences in CI-aided thresholds and speech perception were observed between manufacturers, potentially related to brand-specific T-level programming approaches.